UGC
Transparency Market Research (TMR) has published a new report titled, “Substance Abuse Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.The report suggests that emerging initiatives by manufacturers and governments and rise in abuse of prescription drugs are anticipated to boost the global substance abuse treatment market from 2018 to 2026.North America and Europe are expected to dominate the global substance abuse treatment market in the next few years, owing to market availability of new drugs and technology, rigorous research and development by major companies, and strong medical infrastructure.Key events in the market include submission of provisional patent application to the USPTO for proprietary pure cannabidiol compositions by Normaco in October 2018, approval of SUBLOCADE, by the FDA, launched in the U.S. in March 2018, and U.S. FDA approval for the ANDA for methadone hydrochloride (5 mg and 10 mg) tablets for Glenmark Pharmaceuticals and its strategic partner Elite Pharmaceuticals, Inc in August 2018.High market attractiveness of drug abuse treatment and nicotine addiction treatment segments is due to the availability of different nicotine replacement products over-the-counter in order to combat tobacco and nicotine addiction and an increase in adoption of prescription opioids or illicit drugs.Nicotine replacement therapy (NRT) products contain low concentration of nicotine, which helps reduce cravings caused by nicotine addiction over time.
UGC
The global opioid use disorder (OUD) market size is projected to reach USD 4.50 billion by 2026, exhibiting a CAGR of 10.8% during the forecast period.Increasing addiction to opioids across the globe will be the central force driving the growth of this market, shares Fortune Business Insights™ in its recent report, titled “Opioid Use Disorder (OUD) Market Size, Share & Industry Analysis, By Drug Class (Buprenorphine, Methadone, and Naltrexone), By Route of Administration (Oral, and Parenteral), By Distribution Channel (Hospital Pharmacies, Retails Pharmacies & Stores, and Online Pharmacies), and Regional Forecast, 2019-2026Click here to get the short-term and long-term impact of COVID-19 on this Opioid Use Disorder (OUD) Market.Please visit: https://www.fortunebusinessinsights.com/opioid-use-disorder-oud-market-102674 Detailed Table of Content: Introduction1.1.Definitions and AssumptionsExecutive SummaryMarket Dynamics3.1.Industry Developments Such as Mergers, Acquisitions, and CollaborationsGlobal Opioid Use Disorder (OUD) Market Analysis, Insights and Forecast, 2015-20265.1.Market Analysis, Insights and Forecast – By Distribution Channel5.4.1.
UGC
Opioids Market Information: By Product (Extended-Release/Long-Acting Opioid, Immediate Release/Short Acting Opioid), by Application (Pain Relief, Anesthesia, Cough Suppression, Deaddiction, Others), by End User, and by Region — Global Forecast till 2023Market Highlights:The global opioids market is expected to register a CAGR of 7.12% during the forecast period with a market value of USD 19,554.49 million in 2017.Opioids are a type of narcotic pain medications that are used to treat moderate to severe pain medications.According to the National Health Interview Survey 2017, 25.3 million Americans suffer from chronic pain daily and 23.4 million people reported their pain as severe.The increasing use of opioids for disease condition causing chronic pains such as cancers, arthritis, lower back pain, and fibromyalgia, favorable reimbursement policies for palliative care in developed regions, and substantial rise in road accidents, trauma, and surgical procedures have led to the growth of the global opioids market in the recent years.However, rising addiction and death cases due to an overdose of opioid are likely to restrain market growth over the forecast period.Intended AudiencePharmaceutical CompaniesResearch InstitutesHospitalsAcademic InstitutesAvail a Free [email protected] https://www.medgadget.com/2019/11/global-opioids-market-size-2019-industry-analysis-growth-share-segments-key-innovative-product-development-strategies-top-key-players-and-future-trends-analysis-by-2023.html Segment analysisThe global opioids market, by product, has been segmented into extended-release/long-acting opioids and immediate-release/short-acting opioids.The extended-release opioid segment is further segmented into oxycodone, oxymorphone, morphine, hydromorphone, and others.On the basis of end user, the global opioids market is segmented into hospitals & clinics, pharmacies, and academic research institutes.Regional AnalysisThe Americas is expected to hold the largest share of the global opioids market.
2
UGC
Opioids Market Information: By Product (Extended-Release/Long-Acting Opioid, Immediate Release/Short Acting Opioid), by Application (Pain Relief, Anesthesia, Cough Suppression, Deaddiction, Others), by End User, and by Region — Global Forecast till 2023Market Highlights:The global opioids market is expected to register a CAGR of 7.12% during the forecast period with a market value of USD 19,554.49 million in 2017.Opioids are a type of narcotic pain medications that are used to treat moderate to severe pain medications.According to the National Health Interview Survey 2017, 25.3 million Americans suffer from chronic pain daily and 23.4 million people reported their pain as severe.The increasing use of opioids for disease condition causing chronic pains such as cancers, arthritis, lower back pain, and fibromyalgia, favorable reimbursement policies for palliative care in developed regions, and substantial rise in road accidents, trauma, and surgical procedures have led to the growth of the global opioids market in the recent years.However, rising addiction and death cases due to an overdose of opioid are likely to restrain market growth over the forecast period.Intended AudiencePharmaceutical CompaniesResearch InstitutesHospitalsAcademic InstitutesAvail a Free [email protected] https://www.medgadget.com/2019/09/orthodontic-supplies-market-2019-services-size-technology-key-players-growth-analysis-future-trends-demand-global-share-and-regional-development-and-forecast-to-2023.html Segment analysisThe global opioids market, by product, has been segmented into extended-release/long-acting opioids and immediate-release/short-acting opioids.The extended-release opioid segment is further segmented into oxycodone, oxymorphone, morphine, hydromorphone, and others.On the basis of end user, the global opioids market is segmented into hospitals & clinics, pharmacies, and academic research institutes.Regional AnalysisThe Americas is expected to hold the largest share of the global opioids market.
UGC
Global Veterinary Pain Management Market: Information by Product (Medication (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Local Anesthetics, A2-Adrenergic Agonists, Muscle Relaxants, Sedatives), Route of Administration (Oral, Parental, Topical), Devices (Laser Therapy Devices, Electromagnetic Therapy Devices)), Application (Joint Pain (Osteoarthritis, Musculoskeletal Disorders), Postoperative Pain, Cancer, Others) End User (Hospitals & Clinics, Ambulatory Surgery Centers and Others), Distribution Channel (Hospitals and Clinics, Pharmacies, others) - Forecast till 2027Market Highlights:Veterinary Pain Management Market is growing rapidly and pervasively mainly due to the spreading awareness towards animal care.People are generally compassionate towards their pets, and they are increasingly becoming aware of animal physiology and psychology and the pain they go through during sickness, injuries, recoveries and after effects of the diseases.Besides, factors such as the increasing number of pet owners and the strengthening bond between owners and their animal companions escalate the market on the global heights.Get Sample PDF @https://www.marketresearchfuture.com/sample_request/5961Acknowledging the rapid expansions, the market perceives currently, Market Research Future (MRFR) in its recently published study report asserts that the global veterinary pain management market will reach significant growth heights by 2023 registering 8.2% CAGR during the review period (2018 – 2023).Additional factors substantiating the market growth include the rising per capita income that is leading to increasing the pet adoptions and the trend of nuclear families.Increased awareness concerning animal cruelty is influencing people’s ideologies and knowledge about animals.Moreover, developments in animal health medicines and vaccines, along with the increased medical treatments are fostering the market growth of veterinary pain management market.are contributing to the market growth.Improving economic conditions worldwide foster market growth, enabling access to the quality of life, increasing consumers’ buying power, and availing cost-effective veterinary healthcare.On the other hand, factors such as the lack of awareness and knowledge pertaining to the animal well-being and the rising cost of pet care, etc.Also, technological innovations in the field of veterinary surgical instruments are acting as a tailwind pushing up the market growth in the region.
1
UGC
KD Market Insights provides in-depth analysis in its upcoming report titled Global Pain Therapeutics Trends, Applications, Analysis, Growth, and Forecast to 2025.The Pain Therapeutics market report covers a thorough analysis of the fundamental factors driving the variations in growth patterns in the industry.The scope of the study encompasses both regional and country-level market research.The objective of this study is to strategically analyze each market segment in relation to the individual growth trend and their contribution to the Pain Therapeutics Market in order to optimize return on investment (ROI) by providing consistent information required for informed business decisions.The major focus areas of the report include in-depth analysis of Porter’s five forces, PESTLE analysis, company market share analysis, market segment analysis using market attractiveness and BPS analysis representation.Get sample [email protected]  https://www.kdmarketinsights.com/sample/5403The study delivers analytical and comprehensive information on the numerous main players operating in the global market, their finances, trends in the supply chain, technological advances, key developments, acquisitions & mergers, and the market presence of different players.The study also highlights the major challenges and threats that businesses could face due to the unprecedented outbreak of COVID-19 and provides strategies that can be adopted in order to survive in the situation of COVID-19.A comprehensive competitive overview, including market share and company profiles of key players operating in the global market, is covered in the report.Following are the major companies:- NOVARTIS AG- ELI LILLY & COMPANY- ABBOTT LABORATORIES, INC.- ENDO HEALTH SOLUTIONS, INC.- PURDUE PHARMA L.P.- PFIZER, INC.- F. HOFFMANN LA ROCHE LTD.- MERCK & CO. INC.- JOHNSON & JOHNSON- GLAXOSMITHKLINE PLC.- Other Major & Niche Players.Following are the key segments covered in the report:Based on (By Drug Class), the global Pain Therapeutics market is categorized as:NSAIDs,Anesthetics,Anticonvulsants,Antimigraine Agents,Antidepressants,Opioids [Tramadol, Hydrocodone, Oxycodone, and Others],Nonnarcotic AnalgesicsBased on (By Indication), the global Pain Therapeutics market is categorized as:Arthritic Pain,Neuropathic Pain,Cancer Pain,Chronic Back Pain,Postoperative Pain,MigraineFibromyalgiaBased on (By Distribution Channel), the global Pain Therapeutics market is categorized as:Hospital Pharmacy,Retail Pharmacy Store,Online PharmacyBased on region, the global Pain Therapeutics market is segmented into:North America (U.S. & Canada)Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Rest of  Europe)Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand, and Rest of Asia Pacific)Latin America (Brazil, Mexico, and Rest of Latin America)Middle East & Africa (GCC, North Africa, South Africa, and Rest of Middle East & Africa)Get Complete Research Report with [email protected] https://www.kdmarketinsights.com/product/5403/pain-therapeutics-marketThe Following are the Key Features of Global PAIN THERAPEUTICS Market Report:Market Overview, Industry Development, Market Maturity, PESTLE Analysis, Value Chain AnalysisGrowth Drivers and Barriers, Market Trends & Market OpportunitiesPorter’s Five Forces Analysis & Trade AnalysisMarket Forecast Analysis for 2019-2025Market Segments by Geographies and CountriesMarket Segment Trend and ForecastMarket Analysis and RecommendationsPrice AnalysisKey Market Driving FactorsPain Therapeutics Market Company Analysis: Company Market Share & Market Positioning, Company Profiling, Recent Industry Developments etc.Why Choose KD Market Insights?Driven by a team of vibrant industry experts, best-trained analysts and consultants from the industry.Committed to assist clients by providing them with comprehensive, value- added solutions and professional market intelligence services.In-depth analysis of facts acquired with actionable perspectives.Strong morals and ethics in presenting the data.Get Discount [email protected] https://www.kdmarketinsights.com/discount/5403About Us:KD Market Insights offers a comprehensive database of syndicated research studies, customized reports, and consulting services.
1
UGC
Summary - A new market study, titled “Global Opioids Market Research Report Forecast to 2023” has been featured on WiseGuyReports.Opioids are drugs that act on the nervous system to relieve pain.The market for opioids is increasing due to the growing geriatric population, coupled with an increasing focus on palliative care and technological advancements in opioids.However, drug misuse and addiction are likely to hamper the market growth over the forecast period.The global opioids market is expected to reach USD 29,535.80 million by 2023 from USD 19,554.49 million in 2017 and is expected to register a CAGR of 7.12% during the forecast period of 2018 to 2023.In 2017, the market was led by the Americas with a 77.49% share, followed by Europe, and Asia-Pacific with shares of 10.69% and 8.1%, respectively.The market has been segmented based on product, application, and end-user.The global opioids market on the basis of product has been segmented into immediate-release/short-acting opioid and extended-release/long-acting opioid.Anesthesia is further sub-segmented into cough suppression, diarrhea suppression, and de-addiction.
1
UGC
 The global opioid use disorder (OUD) market size is projected to reach USD 4.50 billion by 2026, exhibiting a CAGR of 10.8% during the forecast period.Increasing addiction to opioids across the globe will be the central force driving the growth of this market, shares Fortune Business Insights™ in its recent report, titled “Opioid Use Disorder (OUD) Market Size, Share & Industry Analysis, By Drug Class (Buprenorphine, Methadone, and Naltrexone)Highlights of the Report: In-depth analysis of various insights, namely, Opioid Use Disorder (OUD) Market trends, growth drivers, opportunities, and other related challenges.Comprehensive details of key market players, their core competencies, and Opioid Use Disorder (OUD) Market share.The potency of suppliers and buyers to make better business decisions.Lists out the market size in terms of volume.Definitions and AssumptionsExecutive SummaryMarket Dynamics3.1.Industry Developments Such as Mergers, Acquisitions, and CollaborationsGlobal Opioid Use Disorder (OUD) Market Analysis, Insights and Forecast, 2015-20265.1.Market Analysis, Insights and Forecast – By Distribution Channel5.4.1.Rest of EuropeAsia Pacific Opioid Use Disorder (OUD) Market Analysis, Insights and Forecast, 2015-20268.1.
UGC
The report includes basic information along with advanced market statistics of the global Opioids market.Accurate information about the market dynamics along with future growth prospects are analyzed in the report.Different strategies undertaken by market players in order to get a competitive advantage over their competitors and increase their global market reach are also studied comprehensively in the report.The chapter on market dynamics includes market drivers, restraints, and opportunities which help familiarize with market potential and upcoming opportunities.The chapter on key insights includes emerging trends from major countries, latest technological advancement, regulatory landscape, SWOT analysis, and porters five forces analysis.The chapter on competitive analysis includes profiling of leading companies in the global market to map the leading companies and their focus of interest in the market.For More Enquiry and Discount related quarries: https://www.datalibraryresearch.com/enquiry/opioids-market-2195SegmentationThe global Opioids market has been segmented on the basis of production, region, market share and so on.*All our reports are customizable as per customer requirementsThis study forecasts revenue and volume growth at global, regional, and country levels from 2016 to 2027.
UGC
The latest trending report Global Opioids Drug Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 offered by DecisionDatabases.com is an informative study covering the market with detailed analysis.The report will assist reader with better understanding and decision making.The Opioids Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.The global Opioids Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of -1.7%% in the forecast period of 2020 to 2025 and will expected to reach USD 10020 million by 2025, from USD 10740 million in 2019.Final Report will cover the impact of COVID-19 on this industry.Browse the complete report and table of contents @ https://www.decisiondatabases.com/ip/21831-opioids-drug-market-analysis-reportThe major players covered in Opioids Drug are: TevaPfizerAmneal PharmaPurdue PharmaEndoMallinckrodtMylanJCollegiumINSYSHikmaEgaletBy Type, Opioids Drug market has been segmented intoOxycodoneHydromorphoneCodeineFentanylOtherBy Application, Opioids Drug has been segmented into:Pain ReliefAnesthesiaOtherThe report offers in-depth assessment of the growth and other aspects of the Opioids Drug market in important countries (regions), including:North America (United States, Canada and Mexico)Europe (Germany, France, UK, Russia and Italy)Asia-Pacific (China, Japan, Korea, India and Southeast Asia)South America (Brazil, Argentina, etc.)Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)Download Free Sample Report of Global Opioids Drug Market @ https://www.decisiondatabases.com/contact/download-sample-21831The content of the study subjects, includes a total of 15 chapters:Chapter 1, to describe Opioids Drug product scope, market overview, market opportunities, market driving force and market risks.Chapter 2, to profile the top manufacturers of Opioids Drug, with price, sales, revenue and global market share of Opioids Drug in 2018 and 2019.Chapter 3, the Opioids Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.Chapter 4, the Opioids Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.Chapter 12, Opioids Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.Chapter 13, 14 and 15, to describe Opioids Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.Purchase the complete Global Opioids Drug Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-21831All Drugs Related Reports by DecisionDatabases.com @ https://goo.gl/knWRNbAbout-Us:DecisionDatabases.com is a global business research report provider, enriching decision makers and strategists with qualitative statistics.DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.We provide intellectual, precise and meaningful data at a lightning speed.For more details:DecisionDatabases.comE-Mail: [email protected]: +91 9028057900Web: https://www.decisiondatabases.com/
UGC
KD Market Insights has published a report on global Pain Therapeutics market research report.The report offers valuable market insights drivers which would aid the industry leaders to develop and line up their market strategies supported by reliable and accurate data.The market was held to USD XX.X Million in 2019 and is projected to reach to a valuation of USD XX.X Million in 2025.The report covers a detailed chapter on market segmentation of Pain Therapeutics market covering market segments By Drug Class, By Indication and By Distribution Channel.The report offers an exhaustive analysis of the market trends, opportunities, growth areas and industry drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.Get sample [email protected] https://www.kdmarketinsights.com/sample/5403On the basis of By Drug Class, the market is examined across – NSAIDs, Anesthetics, Anticonvulsants, Antimigraine Agents, Antidepressants, Opioids [Tramadol, Hydrocodone, Oxycodone, and Others], and Nonnarcotic Analgesics.Each sub-segment covers various aspect of market and delivers market size and year-on-year growth.This research report studied the Pain Therapeutics market to forecast the revenues and analyze the trends in 5 regions i.e.This chapter of the report presents a comparison between emerging regions and developed regions to highlight the key factors and industry trends impacting the overall Pain Therapeutics market.
2
UGC
Global "Opioids Market" 2025 Industry research report covers the industry overview with Marketplace Size, Share, Development, futuristic cost, earnings, demand and distribution data.Its vast repository offers an analytical summary of the marketplace that can help to the new and existing player to take a significant decision.This report provides players with useful information and suggests result-based ideas to give them a competitive advantage in the global Opioids industry.It will show how other players compete in the global Opioids Market and explain the strategies you use to differentiate yourself from other participants.However, when opioids are taken in high quantity it leads to risk of mortality and dependence in patients.To treat severe and moderate pain opioids are mainly used.
UGC
Transparency Market Research (TMR) has published a new report titled, ‘Radiofrequency Ablation Devices for Pain Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.According to the report, the global radiofrequency ablation devices for pain management market was valued at US$ 543.0 Mn in 2018 and is projected to expand at a CAGR of above 11.0% from 2019 to 2027.Overview Radiofrequency ablation is a minimally invasive surgical procedure that involves a local anesthetic and mild sedation.This procedure is primarily used to reduce chronic low-back and neck pain.The procedure involves heating a small area of nervous tissue under controlled temperature and as a result help in blockage of pain signals transmitting from that area.North America dominated the global radiofrequency ablation devices for pain management market in 2018 and the trend is anticipated to continue during the forecast period.Rise in awareness regarding the treatment benefits, high incidence rate of chronic pain among the population in the U.S. are expected to drive the market in North America.However, Asia Pacific is likely to be a highly lucrative market for radiofrequency ablation devices for pain management and it is expected to expand at a high CAGR during the forecast period Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=985 Growing adoption of RF ablation for pain management among end-users to Drive Market Pain leads to severe complications, if proper care or treatment is not taken for a long time.High adverse effects and lower efficiency of alternate pain relief procedures and therapeutics such as opioids, acupuncture, and acupressure has led to surge in adoption of radiofrequency ablation devices, which offer better treatment with minimal side effects.Hence, high availability, easy access, increased awareness, cost-effectiveness, and quick relief provide RF ablation devices for pain management a cutting edge over other treatment options.
UGC
Transparency Market Research (TMR) has published a new report titled, ‘Pain Management Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.According to the report, the global Pain Management Therapeutics market was valued at US$ 66,558.6 Mn in 2018 and is projected to expand at a CAGR of 3.7% from 2019 to 2027.Overview Pain is the result of potential tissue damage which leads to an unbearable sensory and emotional experience.According to the International Association for the Study of Pain (IASP), pain can be further categorized based on certain factors such as region of the body involved, duration, intensity of pain and etiology.The first line of treatment in pain management usually involves the use of pharmaceuticals from various therapeutic classes such as antidepressants, opioids, NSAIDs, anticonvulsants, anesthetics and other non-narcotic analgesics.North America dominated the global pain management therapeutics market in 2018 and the trend is anticipated to continue during the forecast period.Highly structured health care industry, advancement in health care facilities in countries such as the U.S., and Canada, and availability of effective and convenient treatment options are expected to drive the market in North America.Asia Pacific is likely to be a highly lucrative market for pain management therapeutics and it is expected to expand at a high CAGR during the forecast period Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=1059 High Incidence of Chronic pain and Increase in Number of Generic Products to Drive Market High incidence of chronic pain is likely to drive the market.The use of generic drugs is expected to increase in the next few years, such factors are helps to fuel the growth of this market.
More

Top